Navigation and Clinical Trials

Chapter

Abstract

Patient navigation can be a means to positively influence oncology clinical trial participation. With a navigation focus on minority and underserved populations, this care concept promotes a trusting relationship among the research staff and the patient population served. An overview of clinical trials is described followed by a historical perspective of clinical trials, and current mandates are reviewed. A background of known barriers to clinical trial participation is disclosed since this is a common focal point of the navigation development in disparate communities. With respect to the individuality of a healthcare system’s focus on increasing oncology clinical trial participation, different avenues of navigation are explored to promote success on this objective. A common foundation for each avenue to increase clinical trial participation is built on the trusting relationship that the navigator establishes with each patient. The logistics of navigation training with standardized metrics that can apply to any navigation program engaged in clinical trial promotion is described. Patient navigation can be employed as a reasonable way to increase oncology clinical trial participation.

References

  1. 1.
    Burhansstipanov L, Krebs LU, Bradley A, Gamito E, Osborne K, Kaur JS. Lessons learned while developing “clinical trials education for native Americans” curriculum. Cancer Control. 2003;10(5):29–36. PMID: 14581902.CrossRefGoogle Scholar
  2. 2.
    Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Transforming clinical research in the United States: challenges and opportunities: workshop summary. Washington, DC: National Academies Press, US; 2010. p. 6. Clinical Trials in Cancer. https://www.ncbi.nlm.nih.gov/books/NBK50895/ Google Scholar
  3. 3.
    Cheng S, Dietrich M, Dilts D. A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of Cancer Therapy Evaluation Program (NCI-CTEP) sponsored studies. Clin Cancer Res. 2010;16(22):5557–63.  https://doi.org/10.1158/1078-0432.CCR-10-0133.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Fouada MN, Corbie-Smith G, Curb D, Howard BV, Mauton C, Simon M, Talavera G, Thompson J, Wang CY, White C, Young R. Special populations recruitment for the Women’s Health Initiative: successes and limitations. J Control Clin Trials. 2004;25:335–52.CrossRefGoogle Scholar
  5. 5.
    Baquet CR, Henderson K, Commiskey P, Morrow JN. Clinical trials—the art of enrollment. Semin Oncol Nurs. 2008;24(4):262–9. https://doi.org/10.1016/j.soncn.2008.08.006.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ulrich CM, James JL, Walker EM, Stine SH, Gore E, Prestidge B, Michalski J, Gwede CK, Chamberlain R, Bruner DW. RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment. Contemp Clin Trials. 2010;31(3):221–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Wujcik D, Wolff SN. Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource. J Health Care Poor Underserved. 2010;21(1 Suppl):38–50.  https://doi.org/10.1353/hpu.0.0251.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112:228–42.  https://doi.org/10.1002/cncr.23157.CrossRefPubMedGoogle Scholar
  9. 9.
    Joseph G, Dohan D. Diversity of participants in clinical trials in an academic medical center: the role of the ‘Good Study Patient?’. Cancer. 2009;115:608–15.CrossRefPubMedGoogle Scholar
  10. 10.
    Brawley O. Recruitment of minorities into clinical trials. In: National Cancer Advisory Board, editors. Conference summary: recruitment and retention of minority participants in clinical cancer research. U.S. Department of Health and Human Services, National Cancer Institute, National Institutes of Health (NIH Pub. No. 96-4182); 1996.Google Scholar
  11. 11.
    Burhansstipanov L. Overcoming psycho-social barriers to Native American cancer screening research. In: National Cancer Advisory Board, editor. Conference summary: recruitment and retention of minority participants in clinical cancer research. U.S. Department of Health and Human Services, National Cancer Institute, National Institutes of Health (NIH Pub. No. 96-4182), November 1996. p. 40–2.Google Scholar
  12. 12.
    Cancer.Net. About clinical trials. 2007. www.cancer.net/navigating-cancer-care/how-cancer-treated/clinical-trials/about-clinical-trials. Accessed 8 Mar 2017.
  13. 13.
    Dimond EP, St. Germain D, Nacpil LM, Zaren HA, Swanson SM, Minnick C, et al. Creating a “culture of research” in a community hospital: strategies and tools from the National Cancer Institute Community Cancer Centers Program. Clinical Trials (London, England). 2015;12(3):246–56.  https://doi.org/10.1177/1740774515571141.CrossRefGoogle Scholar
  14. 14.
    Gonzalez M, Berger M, Bryant D, Ellison C, Harness J, Krasna M, et al. Using a minority matrix and patient navigation to improve accrual to clinical trials. Oncol Issues. 2011;March/April:59–60.CrossRefGoogle Scholar
  15. 15.
    Gonzalez M, Berger M, Bryant D, Ellison C, Harness J, Krasna M, et al. Using a minority matrix and patient navigation to improve accrual to clinical trials. March/April: Oncology Issues; 2011. p. 59–60.Google Scholar
  16. 16.
    National Cancer Institute. Cancer clinical trials factsheet. 2017. www.hahv.org/wp-content/uploads/2016/01/clinical-trial-fact-sheet.pdf
  17. 17.
    National Comprehensive Cancer Network. About NCCN. 2017. https://www.nccn.org/about/default.aspx
  18. 18.
    Freund K, Battaglia T, Calhoun E, Dudley D, Fiscella K, Paskett E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391–9.  https://doi.org/10.1002/cncr.23960.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Commission on Cancer. Cancer program standards: ensuring patient centered care. 2016. https://www.facs.org/quality-programs/cancer/coc/standards
  20. 20.
    Denicoff A, McCaskill-Stevens W, Grubbs S, Bruinooge S, Comis R, Devine P, et al. The National Cancer Institute-American Society of Clinical Oncology cancer trial accrual symposium: summary and recommendations. J Oncol Pract. 2013;9(6):267–76.  https://doi.org/10.1200/JOP.2013.001119.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Wong RSL, Vikram B, Govern FS, Petereit DG, Maguire PD, Clarkson MR, et al. National Cancer Institute’s Cancer Disparities Research Partnership Program: experience and lessons learned. Front Oncol. 2014;4:303.  https://doi.org/10.3389/fonc.2014.00303.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Swanson J, Strusowski P, Mack N, Degroot J. Growing a navigation program using the NCCCP Navigation Assessment Tool. 2012. www.accc-cancer.org/oncology_issues/.../JA12-Growing-a-Navigation-Program.pdf. Accessed 5 Feb 2017.CrossRefGoogle Scholar
  23. 23.
    Newcomer B. A national system approach to oncology patient population management across the continuum of care: how we standardized navigation. Nurs Adm Q. 2014;38(2):138–46.CrossRefPubMedGoogle Scholar
  24. 24.
    Willis A, Reed E, Pratt-Chapman M, Kapp H, Hatcher E, Vaitones V. Development of a framework for patient navigation: delineating roles across navigator types. J Oncol Navig Surviv. 2013;4(6):20–6.Google Scholar
  25. 25.
    Oncology Nursing Society. Oncology nurse navigator core competencies. 2017. www.ons.org/sites/default/files/ONNCompetencies_rev.pdf. Accessed 5 Mar 2017.
  26. 26.
    Freeman H. Patient navigation: a community centered approach to reducing cancer mortality. J Cancer Educ. 2006;21(1):S11–4.  https://doi.org/10.1207/s15430154jce2101s_4.CrossRefGoogle Scholar
  27. 27.
    Moffitt K, Brogan F, Brown C, Kasper M, Rosenblatt J, Smallridge R, et al. Statewide cancer clinical trial navigation service. J Oncol Pract. 2010;6(3):127–32.  https://doi.org/10.1200/JOP.200006.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Holmes D, Majo J, Lyonga D, Alleyne R, Clayton S. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation. Am J Surg. 2012;203(4):415–22.  https://doi.org/10.1016/j.amjsurg.2011.02.005.CrossRefPubMedGoogle Scholar
  29. 29.
    Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, Carrigan A, Igo K, Gonzalez M. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncology Issues. 2014;May–June:44–53.CrossRefGoogle Scholar
  30. 30.
    Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE. Lay patient navigator program implementation for equal access to cancer care and clinical trials. Cancer. 2006;107:2669–77.  https://doi.org/10.1002/cncr.22319.CrossRefPubMedGoogle Scholar
  31. 31.
    Gorelick P, Harris Y, Burnett B, Bonecutter F. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. J Natl Med Assoc. 1998;90:141–5.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Kanekar S, Petereit D. Walking forward: a program designed to lower cancer mortality rates among American Indians in Western South Dakota. South Dakota Med. 2009;62(4):151–9.Google Scholar
  33. 33.
    Guadagnolo BA, Petereit DG, Helbig P, Koop D, Kussman P, Dunn EF, Patnaik A. Involving American Indians and medically underserved rural populations in cancer clinical trials. Clinical Trials (London, England). 2009;6(6):610–7.  https://doi.org/10.1177/1740774509348526.CrossRefGoogle Scholar
  34. 34.
    McClung EC, Davis SW, Jeffrey SS, Kuo M-C, Lee MM, Teng NNH. Impact of navigation on knowledge and attitudes about clinical trials among Chinese Patients undergoing treatment for breast and gynecologic cancers. J Immigr Minor Health. 2013;17(3):976–9.CrossRefGoogle Scholar
  35. 35.
    Cartmell KB, Bonilha HS, Matson T, Bryant DC, Zapka JG, Bentz TA, et al. Patient participation in cancer clinical trials: a pilot test of lay navigation. Contemp Clin Trials Commun. 2016;15(3):86–93.  https://doi.org/10.1016/j.conctc.2016.04.005.CrossRefGoogle Scholar
  36. 36.
    Fouad M, Acemgil A, Bae S, Forero A, Lisovicz N, Martin M, et al. Patient navigation as a model to increase participation of African Americans in cancer clinical trials. J Oncol Pract. 2016;12(6):556–63.  https://doi.org/10.1200/JOP.2015.008946.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Cancer Partnership. Clinical Trials Program at Metropolitan Nashville General Hospital. 2017. www.cancer-alliance.org/research/clinical-trials-program-at-metropolitan-nashville-general-hospital. Accessed 26 Mar 2017.
  38. 38.
    EMPACT. General approaches to minority recruitment for cancer clinical trials: a presentation by the EMPACT consortium. 2012. http://tuh7143yoi527qz2743fa3x7.wpengine.netdna-cdn.com/wp-content/uploads/2012/05/General_Approaches_e508.pdf.
  39. 39.
    St Joseph Hospital. St Joseph Hospital community health needs assessment report. 2014. /www.sjo.org/For-Community/Community-Benefits-Plan.aspx.
  40. 40.
    Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, et al. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncology Issues. 2014;May–June:44–53.Google Scholar
  41. 41.
    Gibbs Cancer Center & Research Institute. 2016 Annual report. 2016. https://gibbscancercenter.org/news-media/annual-reports/#1457639866050-77e7953e-4cd2.
  42. 42.
    Natale-Pereira A, Enard KR, Nevarez L, Jones LA. The role of patient navigators in eliminating health disparities. Cancer. 2011;117:3543–52.  https://doi.org/10.1002/cncr.26264.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Gunn CM, Clark JA, Battaglia TA, Freund KM, Parker VA. An assessment of patient navigator activities in breast cancer patient navigation programs using a nine-principle framework. Health Serv Res. 2014;49:1555–77.  https://doi.org/10.1111/1475-6773.12184.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Fillion L, Cook S, Veillette A, Aubin M, de Serres M, Rainville F, et al. Professional navigation framework: elaboration and validation in a Canadian context. Oncol Nurs Forum. 2012;39(1):E58–69.  https://doi.org/10.1188/12.ONF.E58-E69.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Calhoun EA, Whitley EM, Esparza A, Ness E, Greene A, Garcia R, et al. A national patient navigator training program. Health Promot Pract. 2010;11(2):205–15.  https://doi.org/10.1177/1524839908323521.CrossRefPubMedGoogle Scholar
  46. 46.
    Bryant D, Williamson D, Cartmell K, Jefferson M. A lay patient navigation training curriculum targeting disparities in cancer clinical trials. J Black Nurses Assoc. 2011;22(2):68–75.Google Scholar
  47. 47.
    EMPACT. ENACCT’s free E-learning series primary care provider training program. 2017. http://empactconsortium.com/resource/enaccts-free-e-learning-series-primary-care-provider-training-program.
  48. 48.
    Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, et al. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncol Issues. 2014;May–June:44–53.Google Scholar
  49. 49.
    Ghebre RG, Jones LA, Wenzel J, Martin MY, Durant R, Ford JG. State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer. 2014;120(7):1122–30.  https://doi.org/10.1002/cncr.28570.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, Carrigan A, Igo K, Gonzalez M. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncol Issues. 2014;May–June:44–53.CrossRefGoogle Scholar
  51. 51.
    Bellomo C, Christensen D, Strusowski T. Seasoned navigator: a case study on care transitions in genomic testing and timely treatment decision-making. J Navig Surviv. 2016;7(4):33–4.Google Scholar
  52. 52.
    Academy of Oncology Nurse Navigators. Standardized metrics source document. 2017. www.aonnonline.org/metrics-source-document. Accessed 5 Mar 2017.
  53. 53.
    Strusowski T, Sein E, Johnston D, Gentry S, Bellomo C, Brown E, et al. Standardized evidence-based oncology navigation metrics for all models: a powerful tool in assessing the value and impact of navigation programs. J Navig Surviv. 2017;8(5):220–43.Google Scholar
  54. 54.
    Irinotecan Hydrochloride and Cetuximab with or without Ramucirumab in treating patients with advanced colorectal cancer with progressive disease after treatment with Bevacizumab-Containing Chemotherapy.Google Scholar
  55. 55.
    NCI had no American Indians enrolled in the study and were willing to allow Chuck to take part to determine if the medications reacted differently among this underserved population.Google Scholar
  56. 56.
    Innovation Cancer. Clinical trials. 2015. www.innovationcancer.com/For-Patients/Clinical-Trials.aspx.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Novant Health Derrick L. Davis Cancer CenterWinston-SalemUSA
  2. 2.Native American Cancer Research CorporationPineUSA

Personalised recommendations